The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Biliary Tumor Market Research Report 2025

Global Biliary Tumor Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1712263

No of Pages : 74

Ask Your Query
Synopsis
Biliary Tumor is a form of cancer that develops in the bile duct system, which connects the liver, gallbladder, and small intestine, moving bile – a fluid that helps digest fats – to the small intestine.

The global Biliary Tumor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Biliary Tumor is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Biliary Tumor is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Biliary Tumor in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Biliary Tumor include NuCana, NeoGenomics, Novartis, GlaxoSmithKline and Southwest Oncology Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Biliary Tumor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biliary Tumor.

Report Scope

The Biliary Tumor market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biliary Tumor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biliary Tumor companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

NuCana

NeoGenomics

Novartis

GlaxoSmithKline

Southwest Oncology Group

Segment by Type

Mecine

Surgery

Other

Segment by Application

Hospitals

Clinics

Other

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Biliary Tumor companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biliary Tumor Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Mecine

1.2.3 Surgery

1.2.4 Other

1.3 Market by Application

1.3.1 Global Biliary Tumor Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Biliary Tumor Market Perspective (2019-2030)

2.2 Biliary Tumor Growth Trends by Region

2.2.1 Global Biliary Tumor Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Biliary Tumor Historic Market Size by Region (2019-2024)

2.2.3 Biliary Tumor Forecasted Market Size by Region (2025-2030)

2.3 Biliary Tumor Market Dynamics

2.3.1 Biliary Tumor Industry Trends

2.3.2 Biliary Tumor Market Drivers

2.3.3 Biliary Tumor Market Challenges

2.3.4 Biliary Tumor Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Biliary Tumor Players by Revenue

3.1.1 Global Top Biliary Tumor Players by Revenue (2019-2024)

3.1.2 Global Biliary Tumor Revenue Market Share by Players (2019-2024)

3.2 Global Biliary Tumor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Biliary Tumor Revenue

3.4 Global Biliary Tumor Market Concentration Ratio

3.4.1 Global Biliary Tumor Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biliary Tumor Revenue in 2023

3.5 Biliary Tumor Key Players Head office and Area Served

3.6 Key Players Biliary Tumor Product Solution and Service

3.7 Date of Enter into Biliary Tumor Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Biliary Tumor Breakdown Data by Type

4.1 Global Biliary Tumor Historic Market Size by Type (2019-2024)

4.2 Global Biliary Tumor Forecasted Market Size by Type (2025-2030)

5 Biliary Tumor Breakdown Data by Application

5.1 Global Biliary Tumor Historic Market Size by Application (2019-2024)

5.2 Global Biliary Tumor Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Biliary Tumor Market Size (2019-2030)

6.2 North America Biliary Tumor Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Biliary Tumor Market Size by Country (2019-2024)

6.4 North America Biliary Tumor Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Biliary Tumor Market Size (2019-2030)

7.2 Europe Biliary Tumor Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Biliary Tumor Market Size by Country (2019-2024)

7.4 Europe Biliary Tumor Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Biliary Tumor Market Size (2019-2030)

8.2 Asia-Pacific Biliary Tumor Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Biliary Tumor Market Size by Region (2019-2024)

8.4 Asia-Pacific Biliary Tumor Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Biliary Tumor Market Size (2019-2030)

9.2 Latin America Biliary Tumor Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Biliary Tumor Market Size by Country (2019-2024)

9.4 Latin America Biliary Tumor Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Biliary Tumor Market Size (2019-2030)

10.2 Middle East & Africa Biliary Tumor Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Biliary Tumor Market Size by Country (2019-2024)

10.4 Middle East & Africa Biliary Tumor Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 NuCana

11.1.1 NuCana Company Detail

11.1.2 NuCana Business Overview

11.1.3 NuCana Biliary Tumor Introduction

11.1.4 NuCana Revenue in Biliary Tumor Business (2019-2024)

11.1.5 NuCana Recent Development

11.2 NeoGenomics

11.2.1 NeoGenomics Company Detail

11.2.2 NeoGenomics Business Overview

11.2.3 NeoGenomics Biliary Tumor Introduction

11.2.4 NeoGenomics Revenue in Biliary Tumor Business (2019-2024)

11.2.5 NeoGenomics Recent Development

11.3 Novartis

11.3.1 Novartis Company Detail

11.3.2 Novartis Business Overview

11.3.3 Novartis Biliary Tumor Introduction

11.3.4 Novartis Revenue in Biliary Tumor Business (2019-2024)

11.3.5 Novartis Recent Development

11.4 GlaxoSmithKline

11.4.1 GlaxoSmithKline Company Detail

11.4.2 GlaxoSmithKline Business Overview

11.4.3 GlaxoSmithKline Biliary Tumor Introduction

11.4.4 GlaxoSmithKline Revenue in Biliary Tumor Business (2019-2024)

11.4.5 GlaxoSmithKline Recent Development

11.5 Southwest Oncology Group

11.5.1 Southwest Oncology Group Company Detail

11.5.2 Southwest Oncology Group Business Overview

11.5.3 Southwest Oncology Group Biliary Tumor Introduction

11.5.4 Southwest Oncology Group Revenue in Biliary Tumor Business (2019-2024)

11.5.5 Southwest Oncology Group Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details
List of Tables
List of Tables

Table 1. Global Biliary Tumor Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Mecine

Table 3. Key Players of Surgery

Table 4. Key Players of Other

Table 5. Global Biliary Tumor Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Biliary Tumor Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Biliary Tumor Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Biliary Tumor Market Share by Region (2019-2024)

Table 9. Global Biliary Tumor Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Biliary Tumor Market Share by Region (2025-2030)

Table 11. Biliary Tumor Market Trends

Table 12. Biliary Tumor Market Drivers

Table 13. Biliary Tumor Market Challenges

Table 14. Biliary Tumor Market Restraints

Table 15. Global Biliary Tumor Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Biliary Tumor Market Share by Players (2019-2024)

Table 17. Global Top Biliary Tumor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biliary Tumor as of 2023)

Table 18. Ranking of Global Top Biliary Tumor Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Biliary Tumor Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Biliary Tumor Product Solution and Service

Table 22. Date of Enter into Biliary Tumor Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Biliary Tumor Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Biliary Tumor Revenue Market Share by Type (2019-2024)

Table 26. Global Biliary Tumor Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Biliary Tumor Revenue Market Share by Type (2025-2030)

Table 28. Global Biliary Tumor Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Biliary Tumor Revenue Market Share by Application (2019-2024)

Table 30. Global Biliary Tumor Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Biliary Tumor Revenue Market Share by Application (2025-2030)

Table 32. North America Biliary Tumor Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Biliary Tumor Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Biliary Tumor Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Biliary Tumor Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Biliary Tumor Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Biliary Tumor Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Biliary Tumor Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Biliary Tumor Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Biliary Tumor Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Biliary Tumor Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Biliary Tumor Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Biliary Tumor Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Biliary Tumor Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Biliary Tumor Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Biliary Tumor Market Size by Country (2025-2030) & (US$ Million)

Table 47. NuCana Company Detail

Table 48. NuCana Business Overview

Table 49. NuCana Biliary Tumor Product

Table 50. NuCana Revenue in Biliary Tumor Business (2019-2024) & (US$ Million)

Table 51. NuCana Recent Development

Table 52. NeoGenomics Company Detail

Table 53. NeoGenomics Business Overview

Table 54. NeoGenomics Biliary Tumor Product

Table 55. NeoGenomics Revenue in Biliary Tumor Business (2019-2024) & (US$ Million)

Table 56. NeoGenomics Recent Development

Table 57. Novartis Company Detail

Table 58. Novartis Business Overview

Table 59. Novartis Biliary Tumor Product

Table 60. Novartis Revenue in Biliary Tumor Business (2019-2024) & (US$ Million)

Table 61. Novartis Recent Development

Table 62. GlaxoSmithKline Company Detail

Table 63. GlaxoSmithKline Business Overview

Table 64. GlaxoSmithKline Biliary Tumor Product

Table 65. GlaxoSmithKline Revenue in Biliary Tumor Business (2019-2024) & (US$ Million)

Table 66. GlaxoSmithKline Recent Development

Table 67. Southwest Oncology Group Company Detail

Table 68. Southwest Oncology Group Business Overview

Table 69. Southwest Oncology Group Biliary Tumor Product

Table 70. Southwest Oncology Group Revenue in Biliary Tumor Business (2019-2024) & (US$ Million)

Table 71. Southwest Oncology Group Recent Development

Table 72. Research Programs/Design for This Report

Table 73. Key Data Information from Secondary Sources

Table 74. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Biliary Tumor Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Biliary Tumor Market Share by Type: 2023 VS 2030

Figure 3. Mecine Features

Figure 4. Surgery Features

Figure 5. Other Features

Figure 6. Global Biliary Tumor Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Biliary Tumor Market Share by Application: 2023 VS 2030

Figure 8. Hospitals Case Studies

Figure 9. Clinics Case Studies

Figure 10. Other Case Studies

Figure 11. Biliary Tumor Report Years Considered

Figure 12. Global Biliary Tumor Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Biliary Tumor Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Biliary Tumor Market Share by Region: 2023 VS 2030

Figure 15. Global Biliary Tumor Market Share by Players in 2023

Figure 16. Global Top Biliary Tumor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biliary Tumor as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Biliary Tumor Revenue in 2023

Figure 18. North America Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Biliary Tumor Market Share by Country (2019-2030)

Figure 20. United States Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Biliary Tumor Market Share by Country (2019-2030)

Figure 24. Germany Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Biliary Tumor Market Share by Region (2019-2030)

Figure 32. China Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Biliary Tumor Market Share by Country (2019-2030)

Figure 40. Mexico Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Biliary Tumor Market Share by Country (2019-2030)

Figure 44. Turkey Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. NuCana Revenue Growth Rate in Biliary Tumor Business (2019-2024)

Figure 47. NeoGenomics Revenue Growth Rate in Biliary Tumor Business (2019-2024)

Figure 48. Novartis Revenue Growth Rate in Biliary Tumor Business (2019-2024)

Figure 49. GlaxoSmithKline Revenue Growth Rate in Biliary Tumor Business (2019-2024)

Figure 50. Southwest Oncology Group Revenue Growth Rate in Biliary Tumor Business (2019-2024)

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

Figure 53. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock